Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization
- PMID: 6284627
- DOI: 10.1055/s-2007-1018986
Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization
Abstract
The main intention of this study was to characterize the alpha-adrenoceptor responsible for the inhibition of lipolysis in dog fat cell and to define circumstances that may be associated to a modification of the alpha-mediated antilipolytic effect. Isolated fat cells from omental and subcutaneous adipose tissue from normal and obese dogs were used. Basal and theophylline stimulated lipolysis was studied in the presence of selected alpha-adrenergic agonists and antagonists. The antilipolytic effect of catecholamines is mediated by alpha 2-type adrenoceptors in dog fat cell. The alpha-adrenergic responsiveness is enhanced (or unmasked) in large fat cells of obese dogs and depends on the site from which the adipose tissue sample is taken. The alpha-response is stronger in subcutaneous than in omental adipocytes. In conclusion, the weakened lipolytic responsiveness to epinephrine of obese dog fat cells seems related to an increased alpha-adrenergic response rather than a decreased beta-lipolytic effect. Obesity is a circumstance characterized in the dog fat cell by a modification of the balance between alpha-2 and beta receptors.
Similar articles
-
[Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].J Physiol (Paris). 1980;76(2):133-46. J Physiol (Paris). 1980. PMID: 6249915 French.
-
Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.J Pharmacol Exp Ther. 1987 Sep;242(3):1041-9. J Pharmacol Exp Ther. 1987. PMID: 2821223
-
Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidine.J Pharmacol Exp Ther. 1985 May;233(2):433-40. J Pharmacol Exp Ther. 1985. PMID: 2987483
-
Fat cell adrenoceptors: inter- and intraspecific differences and hormone regulation.Int J Obes. 1985;9 Suppl 1:117-27. Int J Obes. 1985. PMID: 2999011 Review.
-
Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome.Pharmacol Res. 2006 Jun;53(6):482-91. doi: 10.1016/j.phrs.2006.03.009. Epub 2006 Mar 27. Pharmacol Res. 2006. PMID: 16644234 Review.
Cited by
-
An examination of the sources of calcium for contractions mediated by postjunctional alpha 1- and alpha 2-adrenoceptors in several blood vessels isolated from the rabbit.Br J Pharmacol. 1990 Feb;99(2):253-60. doi: 10.1111/j.1476-5381.1990.tb14690.x. Br J Pharmacol. 1990. PMID: 2158371 Free PMC article.
-
Bradykinin enhances GLUT4 translocation through the increase of insulin receptor tyrosine kinase in primary adipocytes: evidence that bradykinin stimulates the insulin signalling pathway.Diabetologia. 1996 Apr;39(4):412-20. doi: 10.1007/BF00400672. Diabetologia. 1996. PMID: 8777990
-
Thermogenic and lipolytic effect of yohimbine in the dog.Br J Pharmacol. 1991 Oct;104(2):514-8. doi: 10.1111/j.1476-5381.1991.tb12460.x. Br J Pharmacol. 1991. PMID: 1797315 Free PMC article.
-
Lipomobilizing effects of procaterol and yohimbine in the conscious dog: comparison of endocrinological, metabolic and cardiovascular effects.Br J Pharmacol. 1989 May;97(1):229-39. doi: 10.1111/j.1476-5381.1989.tb11946.x. Br J Pharmacol. 1989. PMID: 2566353 Free PMC article.
-
Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue.Diabetologia. 2007 May;50(5):1038-47. doi: 10.1007/s00125-007-0614-3. Epub 2007 Feb 23. Diabetologia. 2007. PMID: 17318625
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical